The Diagnostics & Lab Testing Business Brief — Saturday, November 14, 2026
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from Wish List failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
-
Narrated by:
-
By:
Summary
The Diagnostics & Lab Testing Business Brief — Saturday, November 14, 2026
- Molecular Designs earns its first FDA 510(k) clearance (K262789) for the SimplicityDx Panel FluA/FluB/RSV, a multiplex RT-PCR test for anterior nasal swabs for use in CLIA high-complexity laboratories, with a breakaway format designed to reduce waste. (PR Newswire)
- Cerenome reports its first quarter of CNSide diagnostic revenue: $0.7 million net on about $1.55 million in gross billings, contracted coverage representing about 190 million covered lives, and an Aetna agreement effective November 1 covering both tumor cell enumeration and molecular profiling. (GlobeNewswire)
- Owlet Q3 2026: revenue of $30.4 million, subscription revenue of $3.6 million with more than 142,000 Owlet360 paying subscribers, and net income of $1.4 million; the company initiated a camera cable guard safety update and withdrew its full-year 2026 outlook. (Business Wire)
- A JAMA study led by WashU Medicine finds the blood tau fragment eMTBR-tau243 elevated in advanced chronic traumatic encephalopathy as well as Alzheimer's disease; the measurement technology is licensed to C2N Diagnostics, and the marker has not been validated for diagnosing CTE. (WashU Medicine)
- VolitionRx Q3 2026: revenue of about $1.6 million, up 157% year over year, operating loss narrowed to $3.3 million, and its French reimbursement submission for the Nu.Q lung cancer test expected this quarter. (PR Newswire)
No reviews yet
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.